Impact of the 12-gene recurrence score assay on deciding adjuvant chemotherapy for stage II and IIIA/B colon cancer: the SUNRISE-DI study-Reference-Cited by-同舟云学术

Impact of the 12-gene recurrence score assay on deciding adjuvant chemotherapy for stage II and IIIA/B colon cancer: the SUNRISE-DI study

Published:2021-06 Issue:3 Volume:6 Page:100146
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

Oki E.,Watanabe J.,Sato T.,Kagawa Y.,Kuboki Y.,Ikeda M.,Ueno H.,Kato T.,Kusumoto T.,Masuishi T.,Yamaguchi K.,Kanazawa A.,Nishina T.,Uetake H.,Yamanaka T.,Yoshino T.

Funder

Genomic Health Inc

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference27 articles.

1. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer;Andre;N Engl J Med,2004

2. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial;Andre;J Clin Oncol,2009

3. Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer;Haller;J Clin Oncol,2011

4. Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials;Sargent;J Clin Oncol,2009

5. Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Labianca;Ann Oncol,2013

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatments and clinical outcomes in stage II colon cancer patients with 12-gene Oncotype DX Colon Recurrence Score® assay-guided therapy: real-world data;ESMO Open;2024-08

2. Molekularpathologie kolorektaler Karzinome;Die Pathologie;2023-06-05

3. Recurrence monitoring using ctDNA in patients with metastasis of colorectal cancer: COSMOS- oligo study;2023-05-03

4. Impact of the 12-gene recurrence score in influencing adjuvant chemotherapy prescription in mismatch repair proficient stage II/III colonic carcinoma—a systematic review and meta-analysis;International Journal of Colorectal Disease;2023-03-13

5. Cost-effectiveness of precision molecular diagnostic tests for stage II colorectal cancer;Annals of Translational Medicine;2022-12